ImmunoVision
Private Company
Total funding raised: $18.5M
Overview
ImmunoVision is a long-established service and product provider in the immunoassay space, operating from San Diego. Its core business revolves around contract development and manufacturing services (CDMO) for immunoassays, including ELISA and CLIA kits, catering primarily to research, biotech, and pharmaceutical clients. The company leverages decades of experience in immunochemistry to offer custom solutions in plate coating, purification, and labeling. It functions as a key service arm within the broader Calbiotech family, supporting research across autoimmune disorders, infectious diseases, and oncology.
Technology Platform
Expertise in classical immunochemistry and immunoassay development services, including custom microtiter plate coating, protein/antibody purification and labeling, and assay optimization for ELISA/CLIA formats.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded market competing with giant diversified players (e.g., Thermo Fisher, Merck) and numerous specialized reagent/assay developers and CROs. Its differentiation is based on deep expertise in autoimmune reagents, custom service flexibility, and its affiliation with Calbiotech's broader manufacturing capabilities.